Xeris Biopharma Holdings, Inc. (XERS)
8.75
+0.01
(+0.11%)
USD |
NASDAQ |
Aug 25, 16:00
8.75
0.00 (0.00%)
After-Hours: 18:59
Xeris Biopharma Holdings Shareholders Equity (Quarterly) : -9.734M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.734M |
| March 31, 2026 | 13.01M |
| December 31, 2025 | 13.69M |
| September 30, 2025 | -0.861M |
| June 30, 2025 | -19.30M |
| March 31, 2025 | -35.13M |
| December 31, 2024 | -29.62M |
| September 30, 2024 | -28.32M |
| June 30, 2024 | -19.29M |
| March 31, 2024 | -9.178M |
| December 31, 2023 | -6.782M |
| September 30, 2023 | 3.865M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 30.05M |
| December 31, 2022 | 45.19M |
| September 30, 2022 | 55.04M |
| June 30, 2022 | 73.94M |
| March 31, 2022 | 96.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 95.23M |
| September 30, 2021 | -2.461M |
| June 30, 2021 | 19.89M |
| March 31, 2021 | 44.39M |
| December 31, 2020 | 33.76M |
| September 30, 2020 | 14.34M |
| June 30, 2020 | 24.38M |
| March 31, 2020 | 27.07M |
| December 31, 2019 | 14.44M |
| September 30, 2019 | 43.66M |
| June 30, 2019 | 74.79M |
| March 31, 2019 | 107.10M |
| December 31, 2018 | 75.41M |
| September 30, 2018 | 95.12M |
| June 30, 2018 | 109.34M |
| March 31, 2018 | 32.85M |
| December 31, 2017 | 40.05M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 217.65M |
| Aclaris Therapeutics, Inc. | 124.58M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 411.90M |
| Total Liabilities (Quarterly) | 421.64M |
| Debt to Equity Ratio | -29.74 |
| Current Ratio | 1.449 |
| Net Debt Paydown Yield | -0.30% |